Abstract
Polymicrobial bacteraemia involving Streptococcus pneumoniae and other bacteria (e.g. Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenza, viridans streptococci, Salmonella spp.) occurred in 3.4% of our pneumococcal bacteraemia cases. Compared with 308 controls (monomicrobial bacteraemia), the 77 polymicrobial cases included more males (83 vs 62%, p = 0.001), had serious underlying diseases (100 vs 80%, p < 0.001), abdominal infection (18 vs 5%, p < 0.001), nosocomial infection (33 vs 8%, p < 0.001), shock (40 vs 13%, p < 0.001), and higher mortality (52 vs 18%, p < 0.001). Clinicians must be aware that some patients with pneumococcal bacteraemia may have other bacteria in their blood, which would confer higher mortality and may lead to inappropriate or incomplete antibiotic therapy.
Similar content being viewed by others
References
Kiani D, Quinn EL, Burch KH, Madhavan T, Saravolatz LD, Neblett TR (1979) The increasing importance of polymicrobial bacteremia. JAMA 242(10):1044–1047
Reuben AG, Musher DM, Hamill RJ, Broucke I (1989) Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis 11(2):161–183
Cooper GS, Havlir DS, Shlaes DM, Salata RA (1990) Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature. Medicine (Baltimore) 69(2):114–123
Khatib R, Sharma M, Johnson LB, Riederer K, Briski L (2016) Polymicrobial Staphylococcus aureus bacteremia: frequency, distinguishing characteristics and outcome. Diagn Microbiol Infect Dis 86:311–315
Kumagai S, Ishida T, Tachibana H, Ito Y, Ito A, Hashimoto T (2015) Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 34:1839–1847
Bartlett JG, O’Keefe P, Tally FP, Louie TJ, Gorbach SL (1986) Bacteriology of hospital-acquired pneumonia. Arch Intern Med 146(5):868–871
Bouza E, Pintado V, Rivera S, Blazquez R, Muñoz P, Cercenado E et al (2005) Spanish Pneumococcal Infection Study Network (G03/103). Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 11(11):919–924
Cilloniz C, Ewig S, Ferrer M, Polverino E, Gabarrús A, Puig de la Bellacasa J et al (2011) Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 15(5):R209
Goodwin RA, Opal SM (1987) Polymicrobial bacteremic pneumonia: report of three cases caused by Staphylococcus aureus and Streptococcus pneumoniae. Am Rev Respir Dis 136:1005–1006
Sanchez Porto A, Gonzalez Serrano M, Brav Ladrón de Guevara F, Rojas E (1991) Polymicrobial endocarditis caused by Streptococcus pneumoniae and Streptococcus pyogenes in a heroin addict carrying the human immunodeficiency virus. Med Clin (Barc) 96(3):114–115
Oteo J, Alos JI, Gomez-Garces JL (2001) Mixed bacteremic pneumonia by Streptococcus pneumoniae and Haemophilus influenzae. Clin Microbiol Infect 10:571
Grau I, Ardanuy C, Calatayud L, Schulze MH, Liñares J, Pallares R (2014) Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections. Int J Infect Dis 25:59–64
McCabe WR, Jackson GG (1962) Gram-negative bacteremia: I. Etiology and Ecology. Arch Intern Med 110(6):847–855
Clinical Laboratory Standard Institute (2014) Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne
Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, Frazão N et al (2011) Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 49(4):1369–1375
Capdevila O, Pallares R, Grau I, Tubau F, Liñares J, Ariza J, Gudiol F (2001) Pneumococcal peritonitis in adult patients: report of 64 cases with special reference to emergence of antibiotic resistance. Arch Intern Med 161(14):1742–1748
Author contributions
I.G. and R.P. had full access to all data and take responsibility for the integrity and accuracy of the data and analyses. Study concept and design: I.G. and R.P.; acquisition of the data: I.G., C.A., M.H.S., J.L., and R.P.; analysis and interpretation of data: I.G., C.A., M.H.S., J.L., and R.P.; drafting of the manuscript: I.G. and R.P.; critical revision of the manuscript for important intellectual content: I.G., C.A., M.H.S., J.L., and R.P.; statistical analysis: I.G. and R.P.; obtaining funding: J.L., C.A., and R.P.; administrative, technical, or material support: I.G., C.A., M.H.S., J.L., and R.P.; study supervision: I.G. and R.P.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
I. Grau, C. Ardanuy and J. Liñares have received funding from Pfizer unrelated to the current paper. All other authors had no conflicts of interest.
Ethical approval
The Ethics Institutional Review Board approved this study, and they specifically waived the need for informed consent because the study analysed the data retrospectively and the source of data was anonymised.
Funding
This study was supported in part by grants PI 08/1922, PI 06/0647 and PI 11/0763 from the Ministry of Health, Madrid, Spain; and CIBERES—CB06/06/0037, from the ISCIII (Instituto de Salud Carlos III), Madrid, Spain.
Rights and permissions
About this article
Cite this article
Grau, I., Ardanuy, C., Schulze, M.H. et al. Polymicrobial pneumococcal bacteraemia: a case–control study. Eur J Clin Microbiol Infect Dis 36, 911–915 (2017). https://doi.org/10.1007/s10096-016-2885-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2885-4